Spark Therapeutics vs Transcripta Bio
Spark Therapeutics vs Transcripta Bio, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Spark Therapeutics is on 58/100 and Transcripta Bio on 54/100.
Where each one leads
Spark Therapeutics
- our overall score: 58/100 against 54/100
- domain rating: 80/100 against 37/100
- funding raised: $82.8M against $24.0M
Transcripta Bio
- agent readiness: 49/100 against 39/100
At a glance
| Measure | Spark Therapeutics | Transcripta Bio |
|---|---|---|
| What it is | A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases. | AI-powered drug discovery company focused on neurological and neuromuscular diseases, leveraging transcriptomics to accelerate therapeutic development. |
| Category | Biotechnology, Gene Therapy, Healthcare, Pharmaceuticals | Biotechnology, Artificial Intelligence, Drug Discovery, Neurology |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Platform |
| Founded | 2013 | 2023 |
| Headquarters | Philadelphia, United States | Palo Alto, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Spark Therapeutics | Transcripta Bio |
|---|---|---|
| Total funding | $82.8M | $24.0M |
| Latest round | Series B | Series A |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Spark Therapeutics | Transcripta Bio |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 58/100 | 54/100 |
| Traction | 40/100 | 37/100 |
| Team | 90/100 | 50/100 |
| Search visibility | 13/100 | 17/100 |
| Quality | 65/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | D (49/100) |
| Domain ratingLink authority, 0-100 | 80/100 | 37/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Spark Therapeutics | Transcripta Bio |
|---|---|---|
| CDN | Cloudflare | Not detected |
| Frameworks | Jquery | Next.js, Tailwind CSS |
| Analytics | Google Tag Manager | Google Analytics 4 |
What users say
| Measure | Spark Therapeutics | Transcripta Bio |
|---|---|---|
| Reddit sentimentThreads we track | 1 positive, 0 negative across 3 threads | 1 positive, 0 negative across 1 thread |
“The Daily Biotech Pulse: Pfizer Strikes $5.29B COVID Pill Supply Deal With US, Roche's Spark Therapeutics Reports Positive Gene Therapy Readout, EDAP Earnings.”r/conspiracy
“Transcripta Bio Wins the Genomics Category 🧬💻. Transcripta Bio took home the trophy for Genomics, and for good reason. They are bridging the gap between massive transcriptomic data and actual drug candidates.”r/AIDiscoveryAward
Spark Therapeutics vs Transcripta Bio: common questions
Which is better, Spark Therapeutics or Transcripta Bio?
On our 0-100 score Spark Therapeutics rates higher (58/100 against 54/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.
How do Spark Therapeutics and Transcripta Bio compare on the numbers?
Spark Therapeutics leads on our overall score (58/100 against 54/100), domain rating (80/100 against 37/100), funding raised ($82.8M against $24.0M). Transcripta Bio leads on agent readiness (49/100 against 39/100).
What do real users say about Spark Therapeutics and Transcripta Bio?
Spark Therapeutics: 1 positive and 0 negative mentions across 3 Reddit threads we track, mostly in r/conspiracy. Transcripta Bio: 1 positive and 0 negative mentions across 1 Reddit threads we track, mostly in r/AIDiscoveryAward.
Read the full Spark Therapeutics review and pricing or the Transcripta Bio review and pricing. You can also browse other Spark Therapeutics alternatives we track.